Maria Fardis, Ph.D.
DirectoratCRISPR Therapeutics AG· In proxies 2023–2025
Maria Fardis, Ph.D. sits on 1 public board.
Boards1
- CRISPR Therapeutics AGDirector · 1 yr on the boardIndependentAudit, Directors and Executive—Paid as an executive
Board seats come from each company's latest proxy statement.
Experience
- CRISPR Therapeutics AGPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role +32%
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?